The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Role of 5′‐ and 3′‐untranslated regions of mRNAs in human diseases
Abstract
Protein synthesis is often regulated at the level of initiation of translation, making it a critical step. This regulation occurs by both the cis‐regulatory elements, which are located in the 5′‐ and 3′‐UTRs (untranslated regions), and trans‐acting factors. A breakdown in this regulation machinery can perturb cellular metabolism, leading to various physiological abnormalities. The highly structured UTRs, along with features such as GC‐richness, upstream open reading frames and internal ribosome entry sites, significantly influence the rate of translation of mRNAs. In this review, we discuss how changes in the cis‐regulatory sequences of the UTRs, for example, point mutations and truncations, influence expression of specific genes at the level of translation. Such modifications may tilt the physiological balance from healthy to diseased states, resulting in conditions such as hereditary thrombocythaemia, breast cancer, fragile X syndrome, bipolar affective disorder and Alzheimer's disease. This information tends to establish the crucial role of UTRs, perhaps as much as that of coding sequences, in health and disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
Kozak, M. (1986) · Cell · doi:10.1016/0092-8674(86)90762-2 · Cited by 4,741
Pelletier, J., & Sonenberg, N. (1988) · Nature · doi:10.1038/334320a0 · Cited by 1,934
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
PTC124 targets genetic disorders caused by nonsense mutations
Welch, E. M., Barton, E. R., Zhuo, J., Tomizawa, Y., Friesen, W. J., Trifillis, P., Paushkin, S., Patel, M., Trotta, C. R., Hwang, S., et al. (2007) · Nature · doi:10.1038/nature05756 · Cited by 1,137
Untranslated regions of mRNAs.
(2002) · Genome biology · doi:10.1186/gb-2002-3-3-reviews0004 · Cited by 987
Internal ribosome entry sites in eukaryotic mRNA molecules
Hellen, C. U. T., & Sarnow, P. (2001) · Genes & Development · doi:10.1101/gad.891101 · Cited by 986
Upstream Open Reading Frames as Regulators of mRNA Translation
Morris, D. R., & Geballe, A. P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.8635-8642.2000 · Cited by 736
The 3′ untranslated region of messenger RNA: A molecular ‘hotspot’ for pathology?
Conne, B., Stutz, A., & Vassalli, J.-D. (2000) · Nature Medicine · doi:10.1038/76211 · Cited by 530
Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations
Fackenthal, J. D., & Olopade, O. I. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2054 · Cited by 488
The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif
Schaeffer, C., Bardoni, B., Mandel, J., Ehresmann, B., Ehresmann, C., & Moine, H. (2001) · The EMBO Journal · doi:10.1093/emboj/20.17.4803 · Cited by 471
BEFFAGNA, G., OCCHI, G., NAVA, A., VITIELLO, L., DITADI, A., BASSO, C., BAUCE, B., CARRARO, G., THIENE, G., & TOWBIN, J. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.10.005 · Cited by 422
MicroRNAs in Disease and Potential Therapeutic Applications
Soifer, H. S., Rossi, J. J., & Sætrom, P. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300311 · Cited by 394
α-Thalassaemia caused by a polyadenylation signal mutation
Higgs, D. R., Goodbourn, S. E. Y., Lamb, J., Clegg, J. B., Weatherall, D. J., & Proudfoot, N. J. (1983) · Nature · doi:10.1038/306398a0 · Cited by 387
The implications of structured 5′ untranslated regions on translation and disease
Pickering, B. M., & Willis, A. E. (2005) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2004.11.006 · Cited by 339
Muckenthaler, M., Gray, N. K., & Hentze, M. W. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80282-8 · Cited by 297
Mutation of the CDKN2A 5' UTR creates an aberrant initiation codon and predisposes to melanoma
Liu, L., Dilworth, D., Gao, L., Monzon, J., Summers, A., Lassam, N., & Hogg, D. (1999) · Nature Genetics · doi:10.1038/5082 · Cited by 276
Translation matters: protein synthesis defects in inherited disease
Scheper, G. C., van der Knaap, M. S., & Proud, C. G. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2142 · Cited by 264
Cap-dependent and cap-independent translation in eukaryotic systems
Merrick, W. C. (2004) · Gene · doi:10.1016/j.gene.2004.02.051 · Cited by 253
A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA→AAUGAA) leads to the IPEX syndrome
Bennett, C., Brunkow, M., Ramsdell, F., O'Briant, K., Zhu, Q., Fuleihan, R., Shigeoka, A., Ochs, H., & Chance, P. (2001) · Immunogenetics · doi:10.1007/s002510100358 · Cited by 240
Evans, J. R., Mitchell, S. A., Spriggs, K. A., Ostrowski, J., Bomsztyk, K., Ostarek, D., & Willis, A. E. (2003) · Oncogene · doi:10.1038/sj.onc.1206645 · Cited by 233
Translational pathophysiology: a novel molecular mechanism of human disease
Cazzola, M., & Skoda, R. C. (2000) · Blood · doi:10.1182/blood.v95.11.3280 · Cited by 223
Kato, J., Fujikawa, K., Kanda, M., Fukuda, N., Sasaki, K., Takayama, T., Kobune, M., Takada, K., Takimoto, R., Hamada, H., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/321261 · Cited by 211
Two internal ribosome entry sites mediate the translation of p53 isoforms
Ray, P. S., Grover, R., & Das, S. (2006) · EMBO reports · doi:10.1038/sj.embor.7400623 · Cited by 208
Chen, J., Férec, C., & Cooper, D. N. (2006) · Human Genetics · doi:10.1007/s00439-006-0218-x · Cited by 159
The regulation of Foxp3 expression in regulatory CD4+CD25+T cells: Multiple pathways on the road
Zhang, L., & Zhao, Y. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21001 · Cited by 158
Chappell, S. A., Quesne, J. P. C. L., Paulin, F., deSchoolmeester, M. L., Stoneley, M., Soutar, R. L., Ralston, S. H., Helfrich, M., & Willis, A. E. (2000) · Oncogene · doi:10.1038/sj.onc.1203791 · Cited by 138
Niesler, B., Flohr, T., Nöthen, M. M., Fischer, C., Rietschel, M., Franzek, E., Albus, M., Propping, P., & Rappold, G. (2001) · Pharmacogenetics · doi:10.1097/00008571-200108000-00002 · Cited by 134
Inhibition of translation of transforming growth factor-beta 3 mRNA by its 5' untranslated region.
Arrick, B. A., Lee, A. L., Grendell, R. L., & Derynck, R. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.9.4306 · Cited by 131
Organization of the CYP1A cluster on human chromosome 15: implications for gene regulation
Corchero, J., Pimprale, S., Kimura, S., & Gonzalez, F. J. (2001) · Pharmacogenetics · doi:10.1097/00008571-200102000-00001 · Cited by 125
Allerson, C. R., Cazzola, M., & Rouault, T. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.37.26439 · Cited by 122
Structural Determinants of BRCA1 Translational Regulation
Sobczak, K., & Krzyżosiak, W. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109162200 · Cited by 119
Hudder, A., & Werner, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005199200 · Cited by 108
Reamon-Buettner, S. M., Cho, S.-H., & Borlak, J. (2007) · BMC Medical Genetics · doi:10.1186/1471-2350-8-38 · Cited by 102
Aberrant Regulation of Messenger RNA 3′‐Untranslated Region in Human Cancer
de Silanes, I. L., Quesada, M. P., & Esteller, M. (2007) · Analytical Cellular Pathology · doi:10.1155/2007/586139 · Cited by 102
Leaky Scanning and Reinitiation Regulate BACE1 Gene Expression
Zhou, W., & Song, W. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.9.3353-3364.2006 · Cited by 98
Signori, E., Bagni, C., Papa, S., Primerano, B., Rinaldi, M., Amaldi, F., & Fazio, V. M. (2001) · Oncogene · doi:10.1038/sj.onc.1204620 · Cited by 95
Degnin, C., Schleiss, M. R., Cao, J., & Geballe, A. P. (1993) · Journal of Virology · doi:10.1128/jvi.67.9.5514-5521.1993 · Cited by 90
Serotonin Type 3 Receptor Genes: HTR3A, B, C, D, E
Niesler, B., Kapeller, J., Hammer, C., & Rappold, G. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.5.501 · Cited by 78
Tassone, F., Hagerman, R. J., Taylor, A. K., & Hagerman, P. J. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.7.453 · Cited by 78
Sorting out the inherited neuropathies.
Reilly, M. M. (2007) · PubMed · Cited by 71
Morrone, A., Bardelli, T., Donati, M. A., Giorgi, M., Rocco, M. D., Gatti, R., Parini, R., Ricci, R. P., Taddeucci, G., d’Azzo, A., et al. (2000) · Human Mutation · doi:10.1002/(sici)1098-1004(200004)15:4<332::aid-humu5>3.0.co;2-1 · Cited by 69
A novel polyadenylation signal mutation in the α2‐globin gene causing α thalassaemia
Harteveld, C. L., Losekoot, M., Haak, H. L., Heister, J. G. A. M., Giordano, P., & Bernini, L. F. (1994) · British Journal of Haematology · doi:10.1111/j.1365-2141.1994.tb04883.x · Cited by 69
Mihailovich, M., Thermann, R., Grohovaz, F., Hentze, M. W., & Zacchetti, D. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm191 · Cited by 68
Serotonin receptor gene HTR3A variants in schizophrenic and bipolar affective patients.
Niesler, B., Weiß, B., Fischer, C., Nöthen, M. M., Propping, P., Bondy, B., Rietschel, M., Maier, W., Albus, M., Franzek, E., et al. (2001) · Pharmacogenetics · doi:10.1097/00008571-200102000-00003 · Cited by 63
Arrick, B. A., Grendell, R. L., & Griffin, L. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.619-628.1994 · Cited by 61
Missense mutations in the DNA-binding region and termination codon in PAX6
Chao, L.-Y., Mishra, R., Strong, L. C., & Saunders, G. F. (2003) · Human Mutation · doi:10.1002/humu.10163 · Cited by 50
The 5′-Untranslated Region of the FMR1 Message Facilitates Translation by Internal Ribosome Entry
Chiang, P.-W., Carpenter, L. E., & Hagerman, P. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105584200 · Cited by 47
Role of ferritin and ferroportin genes in unexplained hyperferritinaemia
Cazzola, M. (2005) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2004.08.025 · Cited by 40
Vanita, V., Hejtmancik, J. F., Hennies, H. C., Guleria, K., Nürnberg, P., Singh, D., Sperling, K., & Singh, J. R. (2006) · PubMed · Cited by 34
Cremonesi, L., Foglieni, B., Fermo, I., Cozzi, A., Paroni, R. C., Ruggeri, G., Belloli, S., Levi, S., Fargion, S. R., Ferrari, M., et al. (2003) · PubMed · Cited by 31
In sickness and in health: the importance of translational regulation
Reynolds, P. R. (2002) · Archives of Disease in Childhood · doi:10.1136/adc.86.5.322 · Cited by 17
Cited by
5'-UTR RNA G-quadruplexes: translation regulation and targeting
Bugaut, A., & Balasubramanian, S. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks068 · Cited by 642
Barrett, L. W., Fletcher, S., & Wilton, S. D. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0990-9 · Cited by 605
mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases
Maruggi, G., Zhang, C., Li, J., Ulmer, J. B., & Yu, D. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.01.020 · Cited by 507
Kim, J., Eygeris, Y., Gupta, M., & Sahay, G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.014 · Cited by 514
CGG Repeat-Associated Translation Mediates Neurodegeneration in Fragile X Tremor Ataxia Syndrome
Todd, P. K., Oh, S. Y., Krans, A., He, F., Sellier, C., Frazer, M., Renoux, A. J., Chen, K.-C., Scaglione, K. M., Basrur, V., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.03.026 · Cited by 478
Metadata
- Authors
- Chatterjee, S., & Pal, J. K.
- Venue
- Biology of the Cell
- Publisher
- Wiley
- Published
- 2009-05
- Volume
- 101
- Issue
- 5
- Pages
- 251-262
- ISSN
- 0248-4900 (ISSN-L)
- 1768-322X
- OpenAlex
- W2038813685
- Cited by
- 439
- References
- 52
- FWCI
- 11.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.